MarketBeat Instant News Alerts

2 hours ago

Insider Selling: Nurix Therapeutics (NASDAQ:NRIX) Insider Sells 1,452 Shares of Stock

MarketBeat

Nurix Therapeutics, Inc. (NASDAQ:NRIX - Get Free Report) insider Gwenn Hansen sold 1,452 shares of the stock in a transaction that occurred on Monday, November 2nd. The shares were sold at an average price of $26.80, for a total transaction of $38,913.60. Following the completion of the transaction, the insider directly owned 123,452 shares of the company's stock, valued at $3,308,513.60. The trade was a 1.16% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

NASDAQ:NRIX

2 hours ago

Nurix Therapeutics (NASDAQ:NRIX) Stock: Insider Houte Hans Van Sells 2,834 Shares

MarketBeat

Nurix Therapeutics, Inc. (NASDAQ:NRIX - Get Free Report) CFO Hans van Houte sold 2,834 shares of the stock in a transaction on Friday, October 30th. The stock was sold at an average price of $26.28, for a total transaction of $74,477.52. Following the transaction, the chief financial officer directly owned 47,514 shares in the company, valued at $1,248,667.92. The trade was a 5.63% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

NASDAQ:NRIX

2 hours ago

Nurix Therapeutics (NASDAQ:NRIX) Insider Gwenn Hansen Sells 3,957 Shares of Stock

MarketBeat

Nurix Therapeutics, Inc. (NASDAQ:NRIX - Get Free Report) insider Gwenn Hansen sold 3,957 shares of the firm's stock in a transaction on Friday, October 30th. The shares were sold at an average price of $26.28, for a total value of $103,989.96. Following the transaction, the insider owned 123,452 shares of the company's stock, valued at $3,244,318.56. The trade was a 3.11% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

NASDAQ:NRIX

2 hours ago

Pitney Bowes (NYSE:PBI) CEO Kurt James Wolf Sells 51,517 Shares of Stock

MarketBeat

Pitney Bowes Inc. (NYSE:PBI - Get Free Report) CEO Kurt Wolf sold 51,517 shares of the firm's stock in a transaction that occurred on Thursday, October 29th. The shares were sold at an average price of $17.45, for a total transaction of $898,971.65. Following the completion of the transaction, the chief executive officer owned 86,684 shares of the company's stock, valued at $1,512,635.80. This trade represents a 37.28% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.

NYSE:PBI

2 hours ago

Fortive (NYSE:FTV) CAO Sells $1,177,588.72 in Stock

MarketBeat

Fortive Corporation (NYSE:FTV - Get Free Report) CAO Christopher Mulhall sold 17,962 shares of the company's stock in a transaction dated Friday, October 30th. The shares were sold at an average price of $65.56, for a total transaction of $1,177,588.72. Following the completion of the sale, the chief accounting officer owned 44,598 shares in the company, valued at approximately $2,923,844.88. This trade represents a 28.71% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

NYSE:FTV

2 hours ago

Pitney Bowes (NYSE:PBI) CEO Sells $2,434,500.00 in Stock

MarketBeat

Pitney Bowes Inc. (NYSE:PBI - Get Free Report) CEO Kurt Wolf sold 150,000 shares of the firm's stock in a transaction dated Monday, November 2nd. The shares were sold at an average price of $16.23, for a total value of $2,434,500.00. Following the sale, the chief executive officer directly owned 73,184 shares in the company, valued at approximately $1,187,776.32. This represents a 67.21% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

NYSE:PBI

What Intel (INTC) Said on Its Q3 Earnings Call

Alphabet Q3 Earnings Call Highlights

CorMedix (NASDAQ:CRMD) Reaches New 1-Year Low - Here's Why

Amazon.com Q3 Earnings Call Highlights

Americas Silver (TSE:USA) Reaches New 12-Month Low - Here's Why

What ServiceNow (NOW) Said on Its Q3 Earnings Call

Compass Pathways (NASDAQ:CMPS) Stock Falls 7.1% - Should You Sell?

All MarketBeat Instant News Alerts

Sort By

Time Frame

Alert Type

Keywords

2 hours ago

Insider Selling: Gilead Sciences (NASDAQ:GILD) CEO Sells 15,000 Shares of Stock

MarketBeat

NASDAQ:GILD

2 hours ago

Insider Selling: Gilead Sciences (NASDAQ:GILD) CEO Sells 15,881 Shares of Company Stock

MarketBeat

NASDAQ:GILD

2 hours ago

CME Group (NASDAQ:CME) Insider Julie Winkler Sells 10,079 Shares of Stock

NASDAQ:JAZZ

2 hours ago

Apple Q4 Earnings Call Highlights

MarketBeat

NASDAQ:AAPL

Alert Categories

All Alerts

Page 1 of 384

1 2 3 4 5 6 7 Earlier › Earliest »

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

MarketBeat Instant News Alerts

Insider Selling: Nurix Therapeutics (NASDAQ:NRIX) Insider Sells 1,452 Shares of Stock

Nurix Therapeutics (NASDAQ:NRIX) Stock: Insider Houte Hans Van Sells 2,834 Shares

Nurix Therapeutics (NASDAQ:NRIX) Insider Gwenn Hansen Sells 3,957 Shares of Stock

Pitney Bowes (NYSE:PBI) CEO Kurt James Wolf Sells 51,517 Shares of Stock

Fortive (NYSE:FTV) CAO Sells $1,177,588.72 in Stock

Pitney Bowes (NYSE:PBI) CEO Sells $2,434,500.00 in Stock

Trending News

All MarketBeat Instant News Alerts

Insider Selling: Gilead Sciences (NASDAQ:GILD) CEO Sells 15,000 Shares of Stock

Insider Selling: Gilead Sciences (NASDAQ:GILD) CEO Sells 15,881 Shares of Company Stock

CME Group (NASDAQ:CME) Insider Julie Winkler Sells 10,079 Shares of Stock

Fortive (NYSE:FTV) SVP Peter Underwood Sells 48,442 Shares of Stock

BlossomHill Therapeutics (NASDAQ:BLSM) Reaches New 52-Week Low - Here's What Happened

Once Upon A Farm (NYSE:OFRM) Sets New 12-Month Low - What's Next?

WhiteFiber (NASDAQ:WYFI) Sets New 52-Week Low - Should You Sell?

Yuanbao (NASDAQ:YB) Sets New 52-Week Low - Here's What Happened

Bright Minds Biosciences (NASDAQ:DRUG) Reaches New 12-Month Low - Time to Sell?

HIVE Digital Technologies (NASDAQ:HIVE) Hits New 52-Week Low - Time to Sell?

CytomX Therapeutics (NASDAQ:CTMX) Reaches New 52-Week Low - Here's What Happened

ALPS Group Inc Ordinary Share (NASDAQ:ALPS) Shares Set to Reverse Split on Monday, November 9th

Intrepid Potash, Inc (NYSE:IPI) Stock Now Rated "Moderate Buy" by Wall Street Brokerages

Donaldson Maps Growth Strategy, $830M Facet Deal and Margin Expansion

What Tactile Systems Technology (TCMD) Said on Its Q3 Earnings Call

Upwork Q3 Earnings Call Highlights

What Waystar (WAY) Said on Its Q3 Earnings Call

onsemi Q3 Earnings Call Highlights

What Palantir Technologies (PLTR) Said on Its Q3 Earnings Call

SiBone Q3 Earnings Call Highlights

Match Group Q3 Earnings Call Highlights

What Lattice Semiconductor (LSCC) Said on Its Q3 Earnings Call

Jazz Pharmaceuticals Q3 Earnings Call Highlights

Apple Q4 Earnings Call Highlights

Featured Articles and Offers

Alert Categories

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools